Lenvatinib

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Lenvatinib and local guidelines before prescribing.

Tyrosine kinase inhibitor

Mechanism

Multi-kinase inhibitor.

Uses

Thyroid, renal cell, hepatocellular and endometrial cancers.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Hypertension, proteinuria, fatigue, diarrhoea, haemorrhage.

Interactions

Few.

Contraindications and cautions

Uncontrolled hypertension

Monitoring

BP, urine protein, TFT

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

Reduce dose in severe renal or hepatic impairment

Overdose and reversal

Supportive

Special advice

Control BP before starting.

More from the textbook: uses, cautions and other points
Where it is discussed in the book